FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

443555006: Product containing precisely telavancin (as telavancin hydrochloride) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3764186011 Telavancin (as telavancin hydrochloride) 250 mg powder for solution for injection vial en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3764187019 Product containing precisely telavancin (as telavancin hydrochloride) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Telavancin (as telavancin hydrochloride) 250 mg powder for solution for injection vial Has presentation strength numerator unit milligram (qualifier value) true Inferred relationship Some 1
Telavancin (as telavancin hydrochloride) 250 mg powder for solution for injection vial Has basis of strength substance (attribute) Telavancin (substance) true Inferred relationship Some 1
Telavancin (as telavancin hydrochloride) 250 mg powder for solution for injection vial Count of base of active ingredient un false Inferred relationship Some
Telavancin (as telavancin hydrochloride) 250 mg powder for solution for injection vial Has presentation strength numerator value (attribute) 250 (qualifier value) false Inferred relationship Some 1
Telavancin (as telavancin hydrochloride) 250 mg powder for solution for injection vial Has presentation strength denominator unit (attribute) Vial (unit of presentation) true Inferred relationship Some 1
Telavancin (as telavancin hydrochloride) 250 mg powder for solution for injection vial Has unit of presentation Vial (unit of presentation) true Inferred relationship Some
Telavancin (as telavancin hydrochloride) 250 mg powder for solution for injection vial Has presentation strength denominator value un false Inferred relationship Some 1
Telavancin (as telavancin hydrochloride) 250 mg powder for solution for injection vial Has precise active ingredient Telavancin hydrochloride (substance) true Inferred relationship Some 1
Telavancin (as telavancin hydrochloride) 250 mg powder for solution for injection vial est un(e) (attribut) Product containing only telavancin in parenteral dose form (medicinal product form) true Inferred relationship Some
Telavancin (as telavancin hydrochloride) 250 mg powder for solution for injection vial Plays role Antibacterial therapeutic role (role) true Inferred relationship Some
Telavancin (as telavancin hydrochloride) 250 mg powder for solution for injection vial est un(e) (attribut) Product manufactured as parenteral dose form (product) false Inferred relationship Some
Telavancin (as telavancin hydrochloride) 250 mg powder for solution for injection vial est un(e) (attribut) Product containing telavancin (medicinal product) false Inferred relationship Some
Telavancin (as telavancin hydrochloride) 250 mg powder for solution for injection vial a pour principe actif (attribut) Telavancin (substance) false Inferred relationship Some
Telavancin (as telavancin hydrochloride) 250 mg powder for solution for injection vial a une forme pharmaceutique (attribut) Powder for solution for injection true Inferred relationship Some
Telavancin (as telavancin hydrochloride) 250 mg powder for solution for injection vial est un(e) (attribut) TEMPORARY parent for CDs that are not updated false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Canada English language reference set (foundation metadata concept)

Description inactivation indicator reference set

US English

Back to Start